Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Pacira BioSciences, Inc. (PCRX) had Revenue of $196.87M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$196.87M
Net Income	$1.64M
Cost of Goods Sold	$40.30M
Gross Profit	$156.57M
Operating Expenses	$194.53M
Operating Income	$2.34M
Non-Operating Income/Expense	$-1.77M
Pre-Tax Income	$0.57M
Normalized Pre-Tax Income	$0.57M
Income after Taxes	$1.64M
Income from Continuous Operations	$1.64M
Consolidated Net Income/Loss	$1.64M
Normalized Income after Taxes	$1.64M
EBIT	$2.34M
EBITDA	$19.33M
Weighted-Average Shares Outstanding (Basic)	44.57M
Weighted-Average Shares Outstanding (Diluted)	45.04M
Earnings per Share (EPS) (Basic)	$0.05
Earnings per Share (EPS) (Diluted)	$0.05
Balance Sheet Financials
Current Assets	$547.97M
Property, Plant, and Equipment	$140.69M
Long-Term Assets	$716.94M
Total Assets	$1.26B
Current Liabilities	$120.59M
Long-Term Debt	$372.19M
Long-Term Liabilities	$451.22M
Total Liabilities	$571.81M
Common Equity	$693.11M
Tangible Shareholders Equity	$304.80M
Shareholders Equity	$693.11M
Common Shares Outstanding	41.12M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$151.99M
Cash Flow from Investing Activities	$99.48M
Cash Flow from Financial Activities	$-369.63M
Beginning Cash	$276.77M
End Cash	$158.54M
Increase/Decrease in Cash	$-118.23M
Stock-Based Compensation	$57.50M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.54
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.35
Debt to Equity Ratio	0.54
Gross Margin	79.53%
Operating Margin	1.19%
EBIT Margin	1.19%
EBITDA Margin	--
Pre-Tax Profit Margin	0.29%
Profit Margin	0.83%
Free Cash Flow	$136.66M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.26
Receiveable Turnover	1.59
Days Sales in Receivables	56.72
Return on Equity	0.24%
Return on Tangible Equity	0.54%
Return on Assets	0.13%
Return on Investments	0.15%
Book Value Per Share	$16.86
Free Cash Flow per Share	$3.03
Operating Cash Flow per Share	$3.37

Data from Zacks Investment Research, Inc.